Evidence map›Paper›PMID 35062238›Full record

ReviewViruses2021

Antiviral Strategies Using Natural Source-Derived Sulfated Polysaccharides in the Light of the COVID-19 Pandemic and Major Human Pathogenic Viruses.

Bimalendu Ray, Imran Ali, Subrata Jana, Shuvam Mukherjee, Saikat Pal, Sayani Ray, Martin Schütz, Manfred Marschall

Open access · goldAbstract readReview
In one paragraph

Review in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Microorganisms · 2025
    Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Cyanobacterial and microalgae polymers: antiviral activity and applications.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Bimalendu RayDepartment of Chemistry, The University of Burdwan, Burdwan 713104, West Bengal, India.ORCID 0000-0001-6041-8933
Imran AliDepartment of Chemistry, The University of Burdwan, Burdwan 713104, West Bengal, India.
Subrata JanaDepartment of Chemistry, The University of Burdwan, Burdwan 713104, West Bengal, India.
Shuvam MukherjeeDepartment of Chemistry, The University of Burdwan, Burdwan 713104, West Bengal, India.
Saikat PalDepartment of Chemistry, The University of Burdwan, Burdwan 713104, West Bengal, India.
Sayani RayDepartment of Chemistry, The University of Burdwan, Burdwan 713104, West Bengal, India.ORCID 0000-0002-9380-7801
Martin SchützInstitute for Clinical and Molecular Virology, Friedrich-Alexander University (FAU) of Erlangen-Nürnberg, 91054 Erlangen, Germany.
Manfred MarschallInstitute for Clinical and Molecular Virology, Friedrich-Alexander University (FAU) of Erlangen-Nürnberg, 91054 Erlangen, Germany.
University of Burdwan · INFriedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

IZKF Program of Hospital/Universitätsklinikum Erlangen A88-M.M./H.S.Matching Funds Program of the Forschungsstiftung Medizin, Medical Center UKER (Erlangen) together with the Manfred Roth-Stiftung (Fürth) M.M./M.S.
6 · The paper itself

Abstract

Only a mere fraction of the huge variety of human pathogenic viruses can be targeted by the currently available spectrum of antiviral drugs. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak has highlighted the urgent need for molecules that can be deployed quickly to treat novel, developing or re-emerging viral infections. Sulfated polysaccharides are found on the surfaces of both the susceptible host cells and the majority of human viruses, and thus can play an important role during viral infection. Such polysaccharides widely occurring in natural sources, specifically those converted into sulfated varieties, have already proved to possess a high level and sometimes also broad-spectrum antiviral activity. This antiviral potency can be determined through multifold molecular pathways, which in many cases have low profiles of cytotoxicity. Consequently, several new polysaccharide-derived drugs are currently being investigated in clinical settings. We reviewed the present status of research on sulfated polysaccharide-based antiviral agents, their structural characteristics, structure-activity relationships, and the potential of clinical application. Furthermore, the molecular mechanisms of sulfated polysaccharides involved in viral infection or in antiviral activity, respectively, are discussed, together with a focus on the emerging methodology contributing to polysaccharide-based drug development.

Indexed as

Antiviral AgentsBiological ProductsCOVID-19COVID-19 Drug TreatmentHeparinHumansPolysaccharidesSARS-CoV-2Structure-Activity RelationshipSulfatesVirus DiseasesVirusesVirus InternalizationAntiviral AgentsBiological ProductsHeparinPolysaccharidesSulfatesantiviral activities and mechanismsantiviral efficacydrug structure-activity relationshipemerging viral infectionsheparin mimeticsin vivo studiesmajor human pathogenic virusessulfated polysaccharidesvirus entry as a target

Identifiers

PMID35062238
PMCPMC8781365
OpenAlexW4206422735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.